[Guanidine nucleotide binding proteins as membrane signal transduction components and regulators of enzymatic effectors]

Effects of carbachol and (-)-N6-phenylisopropyladenosine on myocardial inositol phosphate content and force of contraction

1. The effects of carbachol and the A1-adenosine receptor agonist (-)-N6-phenylisopropyladenosine (PIA) on force of contraction and inositol lipid metabolism were studied in electrically driven left auricles and papillary muscles isolated from guinea-pig hearts. Both carbachol and PIA (0.01-10 microM) had concentration-dependent negative inotropic effects in auricles. In papillary muscles PIA had no inotropic effect. Carbachol also had no inotropic effect at low concentrations (0.01-1 microM) but at 10-100 microM it exerted a slight positive inotropic effect. 2. In auricles and papillary muscles both carbachol and PIA concentration-dependently increased inositol trisphosphate (IP3; significant at 1 microM). Accordingly phosphatidylinositol bisphosphate (PIP2), the precursor of IP3, was reduced. All effects of carbachol and PIA were antagonized by atropine (10 microM) and 1,3-dipropyl-8-cyclopentylxanthine (DPCPX; 20 microM) respectively, indicating receptor-mediated effects. 3. In auricles the negative inotropic effects of carbachol and PIA preceded the increase in IP3. 4. In papillary muscles the increase in IP3 preceded the slight positive inotropic effect of carbachol, indicating that the M-cholinoceptor-mediated increase in IP3 and force of contraction may be related. However, PIA showed a comparable increase in IP3 but no inotropic effect, indicating a dissociation between those parameters. 5. In conclusion, in previous studies a close relation between increases in IP3 and force of contraction has been shown after alpha 1-adrenoceptor stimulation. The present study with carbachol supports this view. However, the present data for PIA could not show such a close relationship, questioning the role of IP3 as an endogenous regulator of force of contraction.

[Inositol trisphosphate, a new "second messenger" for positive inotropic effects on the heart?]

Myocardial alpha 1-adrenoceptors mediate a positive inotropic effect and influence the inositol phosphate cycle. The receptor-stimulated, phospholipase C-mediated hydrolysis of phosphatidylinositol bisphosphate (PIP2) results in the generation of two novel second messengers, inositol trisphosphate (IP3) and diacylglycerol (DG). This effect is concentration-dependent and precedes the increase in force of contraction. Recently, it has been shown that the alpha 1-adrenoceptor-mediated increase in IP3 and force of contraction exists in the human heart as well. Possible mechanisms for an inositol phosphate-mediated positive inotropic effect are: (i) release of Ca2+ from the sarcoplasmic reticulum, elicited by IP3, (ii) increase in Ca2+ sensitivity of the contractile proteins, elicited by IP3, inositol tetrakisphosphate (IP4) and/or DG, (iii) increase in slow Ca2+ inward current, elicited directly by IP4 and/or indirectly by DG through a phosphorylation of the protein kinase C substrate in the sarcolemma. In ventricular cardiac preparations muscarinic agonists have a weak positive inotropic effect, but in cardiac atrial preparations they have a negative inotropic effect. In both preparations, these different effects coincide with a concentration-dependent increase in IP3. Thus, the possible positive inotropic effect in atrial preparations is probably masked by an activation of a K+ outward current. The relationship between the inositol phosphate cycle and the positive inotropic effect is in some points still speculative because not all of the mechanisms discussed are well settled yet. However, the stimulation of myocardial phosphoinositide breakdown resulting in an increased IP3 may be involved in the mechanism(s) whereby alpha1-adrenergic and muscarinic receptor stimulation exert an increase in myocardial force of contraction.(ABSTRACT TRUNCATED AT 250 WORDS)

[Functional guanine nucleotide-binding proteins in receptor-mediated modulation of voltage-dependent ion channels]

G-proteins act as transducers between cell surface receptors activated by extracellular signals and enzymatic effectors which control the concentrations of cytosolic signal molecules such as cAMP, cGMP, inositol phosphates and calcium. The receptor/G-protein-induced changes of the intracellular concentration of such signal molecules correlates with activity changes of various voltage-dependent ion channels. In some instances, cytosolic signal molecules appear to interact directly with ion channels, thereby causing an alteration of ion channel activity. In other instances, signal molecules affect the function of ion channels by activating protein kinases which, in turn, phosphorylate either proteins constituting extracellular signal- and voltage-dependent ion channels or non-identified membranous regulatory components. Recent findings suggest a third, membrane-confined mechanism which does not involve cytosolic signal molecules but a close control of voltage-dependent ion channels by G-proteins. Ion channels that are modulated by extracellular signals according to this newly discovered principle include those for calcium and potassium in neuronal, cardiac and endocrine cells. G-proteins involved in the hormonal stimulation of potassium and calcium channels belong to the family of Gi-type G-proteins which are functionally uncoupled from activating receptors by pertussis toxin. In addition, the cholera toxin-sensitive G-protein, Gs, may directly stimulate cardiac calcium channels. Hormonal inhibition of calcium channels is possibly mediated by Go which, like G-proteins of the Gi-family, is functionally impaired by pertussis toxin.(ABSTRACT TRUNCATED AT 250 WORDS)